7results about How to "Reduce recurrence" patented technology

The invention discloses a multi-model collaborative question-answering method and system for the field of hydraulic cylinders. The method comprises the following steps: constructing a knowledge graph of the field of the hydraulic cylinders; receiving a hydraulic cylinder field problem input by a user, calculating a comprehensive score of the hydraulic cylinder field problem, judging whether the problem belongs to a query type problem or not according to the comprehensive score, if so, matching a template from a preset cross-layer query template library according to a semantic vector of the problem, and if not, matching the template; automatically generating a query statement adaptive to the current problem by combining a component parameter-assembly relationship-design specification three-level association path in the hydraulic cylinder domain knowledge graph, submitting the query statement to a database to execute query, and storing a query result; otherwise, judging whether the problem belongs to a calculation type problem according to the comprehensive score, if so, extracting key parameters in the problem, and calling a calculation program library according to the key parameters to complete calculation to obtain a calculation result; otherwise, integrating the query result and / or the calculation result, and generating an answer of the question.

This invention proposes a visual human tissue rotary cutting device and its shell opening and closing control method, belonging to the field of shell medical device technology. The visual human tissue rotary cutting device includes a scalpel sheath, a blade, a ductoscope, an electrocoagulation hemostatic needle, a sampling chamber, and a puncture shell. The scalpel sheath is capable of axial feeding movement. The blade is installed in the scalpel sheath. The ductoscope is fixedly installed on the outer wall of the scalpel sheath. The electrocoagulation hemostatic needle is installed on the outer wall of the scalpel sheath and located on the opposite side of the ductoscope. The sampling chamber is connected to the scalpel sheath and an external vacuum device. The puncture shell includes a first half-shell and a second half-shell, which can be connected at their tail ends and open at their front ends, forming a bullet shape when combined. The lesion tissue is removed by rotating the blade, which completes axial cutting with the axial feeding of the scalpel sheath. The ductoscope provides the surgeon with a surgical field, which improves surgical accuracy and reduces recurrence. The electrocoagulation hemostatic needle is used to handle large-scale active bleeding.

This invention relates to the field of traditional Chinese medicine (TCM) composition technology. It discloses a TCM formula for treating gout using a warming and dampness-eliminating approach. The TCM composition is made from the following raw materials: kudzu root, yam, cinnamon twig, dioscorea hypoglauca, corydalis rhizome, poria cocos, atractylodes macrocephala, cistanche deserticola, morinda officinalis, and licorice root. Cistanche deserticola and morinda officinalis are the principal herbs to warm and tonify kidney yang, while poria cocos and atractylodes macrocephala are the assistant herbs to strengthen the spleen and eliminate dampness. This warming and dampness-eliminating TCM formula for gout breaks through the limitations of traditional heat-clearing and dampness-eliminating methods, focusing on the pathogenesis of spleen and kidney yang deficiency and internal dampness, treating both the root cause and symptoms, and significantly reducing the recurrence of gout attacks. The entire formula is warming without being drying, does not harm spleen and kidney yang, has high safety, and is suitable for long-term use. The formula is carefully formulated, quickly relieving pain and lowering uric acid, while improving yang deficiency symptoms, with side effects far lower than Western medicine. It has various dosage forms, simple processing, and is easy to produce and promote, providing a safe and effective new solution for gout treatment.

The application relates to the technical field of skin bacteriostatic liquid, and discloses a skin bacteriostatic liquid containing plant extracts and a preparation method thereof, which comprises the following raw materials in parts by mass: composite plant extracts containing nanocrystalline particles 15-20 parts, glycerol 3-4 parts, sodium hyaluronate 0.1-0.2 parts and purified water 75-85 parts. The composite plant extracts containing nanocrystalline particles, glycerol, sodium hyaluronate and purified water are mixed to obtain the skin bacteriostatic liquid, which has the advantages of strong bacteriostasis, long-acting bacteriostasis, mildness and no irritation, and can repair the skin barrier, realize long-acting skin bacteriostasis, reduce the repeated occurrence of skin inflammation, and relieve inflammatory skin aging.

The present invention relates to activated dendritic cells and their use in the treatment of cancer. In particular, the present invention relates to a placental derived heat shock protein gp96-antigen complex, dendritic cells activated by said complex, and pharmaceutical compositions, vaccine adjuvants, immunomodulators and vaccine formulations containing said complex or dendritic cells and their use in anti-tumor.

The invention relates to the technical field of animal husbandry, and discloses a temperature-sensitive sustained-release gel for treating cow mastitis and a preparation method thereof.The temperature-sensitive sustained-release gel is prepared from, by mass, 15%-24% of a triblock copolymer PLGA-PEG-PLGA solution, 3-7 parts of eucommia ulmoides powder, 2-5 parts of nisin, 1-3 parts of a stabilizer, 1-3 parts of a pH regulator and the balance water. One-time perfusion can be completed under the condition of a small administration volume, a stable sustained-release drug library is formed in the local part of the mammary gland, and the drug is continuously and slowly released through the diffusion effect of the gel layer, so that a lasting inhibition effect is generated on pathogenic bacteria on the surface and in the mammary gland tissue. Due to the fact that the medicine mainly plays a role in the local part of the breast, the high local medicine concentration can be maintained in the breast tissue, diffusion of the medicine to the whole body tissue is reduced, and therefore the risk that the medicine has adverse effects on non-lesion organs or tissues is reduced.

This disclosure provides a Yao medicine composition, preparation, preparation method, and application for treating vertigo, belonging to the field of ethnic medicine technology. The composition comprises the following components in parts by weight: 5-20 parts of Bidens pilosa, 5-20 parts of Apocynum venetum leaf, 5-50 parts of Achyranthes bidentata, 5-50 parts of Achyranthes bidentata, 5-50 parts of Prunus persica kernel, 5-20 parts of Carthamus tinctorius, 5-20 parts of Paeonia lactiflora, 5-20 parts of Ligusticum chuanxiong, 5-20 parts of Achyranthes bidentata, 5-20 parts of Zanthoxylum bungeanum, 5-20 parts of Pueraria lobata, and 5-20 parts of Angelica sinensis. The composition and preparation of this invention can effectively treat vertigo caused by hypertension, cervical spondylosis, etc., and have high safety, providing a new and effective solution for the treatment of related diseases.